Filter
1115
Filtered Results: 1115
Text search:
The
Global
Fund
to
Fight
AIDS,
Tuberculosis
and
Malaria
Featured
Recommendations
70
New Publications
334
Language
Document type
No document type
792
Studies & Reports
173
Guidelines
72
Strategic & Response Plan
28
Manuals
26
Fact sheets
9
Situation Updates
6
Infographics
4
Training Material
3
Brochures
1
Resource Platforms
1
Countries / Regions
Global
47
Rwanda
36
Western and Central Europe
34
Liberia
32
Eastern Europe
27
Uganda
26
Nigeria
24
India
24
Sierra Leone
23
Zambia
23
Malawi
23
Kenya
21
Tanzania
21
Lesotho
20
Ethiopia
18
Myanmar / Burma
18
Africa
18
Nepal
17
Bangladesh
17
Namibia
16
Ghana
14
Ukraine
14
Asia
14
South Africa
11
Senegal
9
Cambodia
9
Mozambique
9
South–East Asia Region
9
Latin America and the Carribbean
8
Tajikistan
8
Guinea
7
Zimbabwe
7
Philippines
7
Congo, Democratic Republic of
6
Botswana
6
East and Southern Africa
6
Burkina Faso
5
Cameroon
5
Haiti
5
Albania
5
Pakistan
4
Russia
4
Thailand
3
Benin
3
Eswatini/ Swaziland
3
West and Central Africa
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Venezuela
3
Georgia
3
South Sudan
2
Germany
2
Indonesia
2
North Macedonia
2
Western Pacific Region
2
Armenia
2
Moldova
2
Vietnam
2
Jamaica
2
Somalia
1
Afghanistan
1
Lebanon
1
Syria
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Brazil
1
Serbia
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Laos
1
Timor Leste/ East Timor
1
Romania
1
Uzbekistan
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
435
Clinical Guidelines
61
Public Health
49
Women & Child Health
18
Key Resources
18
Pharmacy & Technologies
14
Capacity Building
5
Toolboxes
HIV
280
TB
187
Health Financing Toolbox
52
COVID-19
39
Global Health Education
24
Mental Health
20
Pharmacy
18
AMR
13
Ebola
11
Planetary Health
9
Polio
8
Conflict
7
Refugee
7
Caregiver
6
Rapid Response
5
Disability
4
NTDs
4
NCDs
4
Cholera
1
Natural Hazards
1
Zika
1
As part of the UN’s data strategy—which seeks to nurture data as a strategic asset for insight, impact and integrity—UNAIDS plays an indispen...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of ... WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tracks progress made with respect to disease burden reduction, elimination and eradication. It also highlights major emerging threats, opportunities and priorities in the fight against commu- nicable and non-communicable diseases in the region. It covers the period 2000-2022, but for some indicators, information is available only up to 2021.
The report shows the number of reported cases for malaria and vaccine preventable diseases (meningitis, measles, yellow fever, pertussis, diphtheria, tetanus, and polio); disease incidence due to HIV, tuberculosis and four major noncommunicable diseases (cardiovas- cular diseases, cancers, diabetes and chronic respira- tory diseases).
Supplement to the Healthcare Waste Management Toolkit for Global Fund
Practitioners ... Policy Makers
The report explores strategies for sustaining the country’s responses to the three diseases ... eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective coverage of HIV, TB, and malaria services in the long run, mindful of macro-fiscal and institutional constraints. The report informs ongoing dialogue within government, including among the Ministry of Health, National Treasury, Council of Governors, and National AIDS Control Council, as well as between government and development partners.
Five years after a global commitment to Fast-Track the HIV response and end ... by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too few countries.
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, ... advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not a mystery. It is a choice. Some leaders are already following the path—and succeeding. It is inspiring to note that Botswana, Eswatini, Rwanda, the United Republic of Tanzania and Zimbabwe have already achieved the 95–95–95 targets, and at least 16 other countries (including eight in sub-Saharan Africa) are close to doing so.
Five years after a global commitment to Fast-Track the HIV response and end ... by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too few countries
The main objective of the malaria prevention and control programme in Somalia is ... prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis and treatment - is a critical component of malaria prevention and control. To achieve the main objective of reducing malaria morbidity and prevention of malaria mortality, the availability of safe, effective, affordable and accessible anti-malarial drugs is a prerequisite.
2020 is a critical year for our Joint Programme as we collectively define the path to getting back on track to ending ... AIDS epidemic by 2030. Our revised timelines for adoption of the next strategy are highly ambitious. We need the full support of all the tremendously dedicated people in UNAIDS-within our staff, our board and all our stakeholders to make this happen.
This report presents findings from research conducted by Economist Impact to assess the health, demographic, social and economic impacts associated...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to...
Background: Comparable estimates of health spending are crucial for the assessment of health systems and to optimally deploy health resources. ... methods used to track health spending continue to evolve, but little is known about the distribution of spending across diseases. We developed improved estimates of health spending by source, including development assistance for health, and, for the first time, estimated HIV/AIDS spending on prevention and treatment and by source of funding, for 188 countries.
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document ... the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO) in 2019. The compendium is intended to support implementation of the people-centred framework user guide. It can also be used independently to inform decisions taken by national tuberculosis (TB) programmes about the implementation of the tools included in this document.
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce ... disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged disease-specific programmes and
financing, thus achieving significant progress.
Donor government disbursements to combat HIV in low- and middle-income countries totaled US$8 billion in 2018, little changed from the US$8.1 billi...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics ... Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beijing Wantai’s TB-IGRA and Qiagen QuantiFERON-TB Gold Plus products. This expands the range of tests available to detect TB infection. Full details are provided in this WHO policy statement.
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with...
